We are monitoring the impact of COVID-19 on Europe Autoimmune Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1127
Share on
Share on

Europe Autoimmune Diagnostics Market Research Report – Segmented By Test Type, Disease Type, End User and Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) – Industry Size, Share, Trends, Growth, Forecast | 2019 – 2024

Pulished: February, 2020
ID: 1127
Pages: 134

The size of the Autoimmune Diagnostics Market in Europe was worth USD 3.64 billion in 2019 and estimated to reach USD 4.38 billion by the end of 2024 with a growing potential of 3.76%.

Autoimmune diseases arise once the immune system attacks one or more of the body's normal parts as if they were invaders. When the immune system fails to identify "self" it may produce immune cells or antibodies that target its own tissues, cells, and organs. Developed countries of Europe have a projected high occurrence rate of autoimmune disorders compared to other regions of the autoimmune disease diagnostics. The strike rate of autoimmune diseases is more in women compared to men. The presence of large untapped opportunities available in the developing Eastern European countries is expected to fuel the growth of the market.

High occurrence of autoimmune disorders, Supportive government policies, increasing public awareness, increased government funding aimed at improving healthcare infrastructure, the introduction of advanced technologies such as novel biomarkers and portable diagnostic equipment are the major factors driving the growth of the market.

The key restraints that inhibiting the growth of the autoimmune diagnostics market are the low prevalence of localized autoimmune disorders as compared to systemic diseases and the growing rate of diagnostics errors.

This report is segmented & sub-segmented into the following categories:

  • By Test Type: Autoantibody Tests, Antinuclear Antibody Tests, Complete Blood Count (CBC), C-reactive protein (CRP), Comprehensive Metabolic Panel, Urinalysis, Erythrocyte Sedimentation Rate (ESR) and Others
  • By Disease Type: Localized Autoimmune Disease Diagnostics (Graves' Disease, Hashimoto's Thyroiditis, Multiple Sclerosis, Type 1 Diabetes, Psoriasis And Others), Systemic Autoimmune Disease Diagnostics (Rheumatoid Arthritis (RA), Ankylosing Spondylitis and Systemic Lupus Erythematosus (SLE))
  • By End User: Hospitals, Research centres and Diagnostic Laboratories
  • By Country: UK, France, Spain, Germany, Italy,  Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

Companies leading the European Autoimmune disease market profiled in this report are Bio-Rad, Siemens Healthcare, Abbott Laboratories, Crescendo Bioscience, Roche Diagnostics SQI Diagnostics, AESKU Diagnostics, INOVA Diagnostics Inc., BioMerieux SA, Beckman Coulter Inc., Hemagen Diagnostics, Quest Diagnostics, Eli Lilly and GlaxoSmithKline Plc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Test Type                              

                                5.1.1 Autoantibody Tests             

                                5.1.2 Antinuclear Antibody Tests              

                                5.1.3 Complete Blood Count (CBC)          

                                5.1.4 C - reactive protein (CRP) 

                                5.1.5 Comprehensive Metabolic panel   

                                5.1.6 Urinalysis 

                                5.1.7 Erythrocyte Sedimentation Rate (ESR)        

                                5.1.8 Others      

                5.2 By Disease Type                       

                                5.2.1 Localized auto immune disease diagnostics              

                                                5.2.1.1 Graves' Disease

                                                5.2.1.2 Hashimoto's Thyroiditis

                                                5.2.1.3 Multiple Sclerosis

                                                5.2.1.4 Type 1 diabetes

                                                5.2.1.5 Psoriasis

                                                5.2.1.6 Others

                                5.2.2 Systemic auto immune disease diagnostics

                                                5.2.2.1 Rheumatoid Arthritis (RA)

                                                5.2.2.2 Ankylosing Spondylitis

                                                5.2.2.3 Systemic Lupus Erythematosus (SLE)

                5.3 By End Users                             

                                5.3.1 Hospitals  

                                "5.3.2 Research centers

 

"             

                                5.3.3 Diagnostic laboratories      

6. Geographical Analysis                                              

                                6.1 Introduction              

                                6.2 U.K

                                6.3 Spain             

                                6.4 Germany     

                                6.5 Italy               

                                6.6 France          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Bio-Rad                        

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Siemens Healthcare                

                8.3 Abbott Laboratories               

                8.4 Crescendo Bioscience                            

                8.5 Roche Diagnostics                    

                8.6 SQI Diagnostics                         

                8.7 AESKU Diagnostics                   

                8.8 INOVA Diagnostics                  

                8.9 BioMerieux SA                          

                8.10 Beckman Coulter Inc.                           

                8.11 Hemagen Diagnostics                          

                8.12 Quest Diagnostics                  

                8.13 Eli lilly                         

                8.14 Glaxosmithkline Plc                              

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Europe Autoimmune Diagnostics Market By Region, From 2019 - 2024 (USD Billion)
  2. Europe Autoimmune Diagnostics Market By Test Type, From 2019 - 2024 (USD Billion)
  3. Europe Autoantibody Tests Market By Region, From 2019 - 2024 (USD Billion)
  4. Europe Antinuclear Antibody Tests Market By Region, From 2019 - 2024 (USD Billion)
  5. Europe Complete Blood Count (CBC) Market By Region, From 2019 - 2024 (USD Billion)
  6. Europe C - reactive protein (CRP) Market By Region, From 2019 - 2024 (USD Billion)
  7. Europe Comprehensive Metabolic panel Market By Region, From 2019 - 2024 (USD Billion)
  8. Europe Urinalysis Market By Region, From 2019 - 2024 (USD Billion)
  9. Europe Erythrocyte Sedimentation Rate (ESR) Market By Region, From 2019 - 2024 (USD Billion)
  10. Europe Other Test Types Market By Region, From 2019 - 2024 (USD Billion)
  11. Europe Autoimmune Diagnostics Market By Disease Type, From 2019 - 2024 (USD Billion)
  12. Europe Localized Autoimmune Diseases Diagnostics Market By Region, From 2019 - 2024 (USD Billion)
  13. Europe Systemic Autoimmune Diseases Diagnostics Market By Region, From 2019 - 2024 (USD Billion)
  14. U.K Autoimmune Diagnostics Market By Test Type, From 2019 - 2024 (USD Billion)
  15. U.K Autoimmune Diagnostics Market By Disease Type, From 2019 - 2024 (USD Billion)
  16. Spain Autoimmune Diagnostics Market By Test Type, From 2019 - 2024 (USD Billion)
  17. Spain Autoimmune Diagnostics Market By Disease Type, From 2019 - 2024 (USD Billion)
  18. Germany Autoimmune Diagnostics Market By Test Type, From 2019 - 2024 (USD Billion)
  19. Germany Autoimmune Diagnostics Market By Disease Type, From 2019 - 2024 (USD Billion)
  20. Italy Autoimmune Diagnostics Market By Test Type, From 2019 - 2024 (USD Billion)
  21. Italy Autoimmune Diagnostics Market By Disease Type, From 2019 - 2024 (USD Billion)
  22. France Autoimmune Diagnostics Market By Test Type, From 2019 - 2024 (USD Billion)
  23. France Autoimmune Diagnostics Market By Disease Type, From 2019 - 2024 (USD Billion)
  24. Europe Localized Autoimmune Disease Diagnostics Market By Type, From 2019 - 2024 (USD Billion)
  25. Europe Graves' Disease Market By Region, From 2019 - 2024 (USD Billion)
  26. Europe Hashimoto's Thyroiditis Market By Region, From 2019 - 2024 (USD Billion)
  27. Europe Multiple Sclerosis Market By Region, From 2019 - 2024 (USD Billion)
  28. Europe Type 1 diabetes Market By Region, From 2019 - 2024 (USD Billion)
  29. Europe Psoriasis Market By Region, From 2019 - 2024 (USD Billion)
  30. Europe Other Localized Autoimmune Diagnostics Market By Region, From 2019 - 2024 (USD Billion)
  31. U.K Localized Autoimmune Disease Diagnostics Market By Type, From 2019 - 2024 (USD Billion)
  32. Spain Localized Autoimmune Disease Diagnostics Market By Type, From 2019 - 2024 (USD Billion)
  33. Germany Localized Autoimmune Disease Diagnostics Market By Type, From 2019 - 2024 (USD Billion)
  34. Italy Localized Autoimmune Disease Diagnostics Market By Type, From 2019 - 2024 (USD Billion)
  35. France Localized Autoimmune Disease Diagnostics Market By Type, From 2019 - 2024 (USD Billion)
  36. Europe Systemic Auto-immune disease diagnostics Market By Type, From 2019 - 2024 (USD Billion)
  37. Europe Rheumatoid Arthritis (RA) Market By Region, From 2019 - 2024 (USD Billion)
  38. Europe Ankylosing Spondylitis Market By Region, From 2019 - 2024 (USD Billion)
  39. Europe Systemic Lupus Erythematosus (SLE) Market By Region, From 2019 - 2024 (USD Billion)
  40. U.K Systemic Auto-immune disease diagnostics Market By Type, From 2019 - 2024 (USD Billion)
  41. Spain Systemic Auto-immune disease diagnostics Market By Type, From 2019 - 2024 (USD Billion)
  42. Germany Systemic Auto-immune disease diagnostics Market By Type, From 2019 - 2024 (USD Billion)
  43. Italy Systemic Auto-immune disease diagnostics Market By Type, From 2019 - 2024 (USD Billion)
  44. France Systemic Auto-immune disease diagnostics Market By Type, From 2019 - 2024 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample